Browse all articles by this author
New clinical trials show beta-blockers offer no benefit and may raise risks for older heart attack survivors with normal heart function.
New 2026 studies link GLP-1 drugs like semaglutide to a 41% lower GLP-1 cancer risk, reduced metastasis
A 2026 Texas A&M study found a two-step regenerative medicine serum triggered bone, joint, and ligament regrowth in mice
New 2026 research on cannabis and the aging brain found larger gray matter volumes in adults 40–77.
A nationwide chlorthalidone recall covers 11,460 bottles of the 25-mg blood pressure medication after dissolution testing failure.
Scratched, cloudy plastic containers release microplastics, BPA, and phthalates into food — chemicals now linked to cancer risk.
Scientists uncover the ovarian cancer cause behind drug resistance and immune therapy failure — here's what the latest 2026 research means for
A single infusion of VERVE-102 reduced LDL cholesterol by up to 62% in early trials. Here's what the latest cholesterol reduction treatment data
High-dose vitamin E can amplify the vitamin blood thinners interaction, raising bleeding and hemorrhagic stroke risk. Learn the dose thresholds
Pulse pressure — the gap between your two blood pressure numbers — is a powerful indicator of arterial stiffness, heart disease risk
New 2026 research from Finland finds HIF-PHI anemia medications may slow cancer cell growth and block tumor blood vessels through a previously
Omeprazole side effects go beyond heartburn relief. New research flags risks to bones, kidneys, nutrient absorption, and brain health with